
The current NVRO market cap is 218.94M. The company's latest EPS is USD -2.9948 and P/E is -1.93.
Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 116.18M | 101.9M | 104.16M | 96.91M | 112.23M |
Operating Income | -11.79M | -35.83M | -25.12M | -13.87M | -54.53M |
Net Income | -8.98M | -25.41M | -19.58M | -15.34M | -53.11M |
Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 362.05M | 386.91M | 511.37M | 425.17M | 415.2M |
Operating Income | -62.85M | -110.93M | 6.16M | -99.31M | -126.23M |
Net Income | -83.07M | -131.36M | 3M | -92.21M | -113.44M |
Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 635.71M | 596.05M | 603.34M | 595.65M | 553.84M |
Total Liabilities | 342.57M | 317.51M | 329.08M | 322.01M | 322.83M |
Total Equity | 293.15M | 278.54M | 274.25M | 273.64M | 231.01M |
Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 789.43M | 574.54M | 602.41M | 635.71M | 553.84M |
Total Liabilities | 400.97M | 270.93M | 278.53M | 342.57M | 322.83M |
Total Equity | 388.46M | 303.62M | 323.88M | 293.15M | 231.01M |
Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -58.83M | -32.66M | -40.77M | -38.03M | -19.44M |
Investing | -7.2M | 25.32M | 15.79M | 9.36M | 14.63M |
Financing | 49.53M | -6.48M | -4.48M | -4.84M | -4.21M |
Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | 1.19M | -41.88M | 24.68M | -58.83M | -19.44M |
Investing | -369.87M | 201.72M | 64.29M | -7.2M | 14.63M |
Financing | 346.91M | -169.38M | -2.46M | 49.53M | -4.21M |
Market Cap | 218.94M |
Price to Earnings Ratio | -1.93 |
Price to Sales Ratio | 0.53 |
Price to Cash Ratio | 2.31 |
Price to Book Ratio | 0.95 |
Dividend Yield | - |
Shares Outstanding | 37.88M |
Average Volume (1 week) | 2.09M |
Average Volume (1 Month) | 1.26M |
52 Week Change | -59.38% |
52 Week High | 14.70 |
52 Week Low | 3.165 |
Spread (Intraday) | 0.01 (0.17%) |
Company Name | Nevro Corp |
Address |
corporation trust center wilmington, delaware 19801 |
Website | https://www.nevro.com |
Industry | surgical,med instr,apparatus (3841) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.